Molecular Intelligence™ Services
Our suite of tumor profiling services allows the physician to customize the level of profiling they deem necessary for each patient.
Our predefined profiles are helpful when navigating potential therapies within or outside guidelines, or when considering clinical trials.
Multi-platform, solid tumor biomarker analysis for therapeutic decision support and clinical trials matching
- treating aggressive cancers, rare or refractory disease
- looking for clinical trial opportunites
Next-Generation Sequencing Cancer Panel
A standalone, solid tumor panel to detect hundreds of hotspot mutations in the cancer genome. This can be performed on very small specimens (typically 8–10 unstained, unbaked and positively charged slides).
The ordering physician can choose which assay(s) to order on an individual basis.
Single or Multiple Marker Analysis
Physician-directed single test or multiple marker analysis is available for any assay in the Caris Molecular Intelligence menu
Molecular Intelligence™ Service, from Caris Life Sciences®, provides evidence-based tumor information that associates biomarker status to agents with potential clinical benefit or potential lack of clinical benefit. Agents associated with clinical benefit are presented based on NCCN Compendium™ inclusion, relevance of tumor type, level of published evidence and strength of biomarker expression. Report information must be considered in conjunction with all other relevant information in respect of a given patient before determining the appropriate course of treatment. The selection of agents for re-treatment from prior chemotherapy regimens lies with the treating physician and must be done with careful consideration. Caris Molecular Intelligence Service was developed and its performance characteristics were determined by Caris Life Sciences, a medical laboratory CLIA-certified in compliance with the U.S. Clinical Laboratory Amendment Act of 1988 and all relevant U.S. state regulations. Caris Molecular Intelligence Service has not been approved by the United States Food and Drug Administration.
Molecular Intelligence™ Service
Find a local doctor who can help you determine if Caris Molecular Intelligence Service may be right for you.